Endothelin-1 and its role in the pathogenesis of infectious diseases
- PMID: 24780317
- PMCID: PMC4538933
- DOI: 10.1016/j.lfs.2014.04.021
Endothelin-1 and its role in the pathogenesis of infectious diseases
Abstract
Endothelins are potent regulators of vascular tone, which also have mitogenic, apoptotic, and immunomodulatory properties (Rubanyi and Polokoff, 1994; Kedzierski and Yanagisawa, 2001; Bagnato et al., 2011). Three isoforms of endothelin have been identified to date, with endothelin-1 (ET-1) being the best studied. ET-1 is classically considered a potent vasoconstrictor. However, in addition to the effects of ET-1 on vascular smooth muscle cells, the peptide is increasingly recognized as a pro-inflammatory cytokine (Teder and Noble, 2000; Sessa et al., 1991). ET-1 causes platelet aggregation and plays a role in the increased expression of leukocyte adhesion molecules, the synthesis of inflammatory mediators contributing to vascular dysfunction. High levels of ET-1 are found in alveolar macrophages, leukocytes (Sessa et al., 1991) and fibroblasts (Gu et al., 1991). Clinical and experimental data indicate that ET-1 is involved in the pathogenesis of sepsis (Tschaikowsky et al., 2000; Goto et al., 2012), viral and bacterial pneumonia (Schuetz et al., 2008; Samransamruajkit et al., 2002), Rickettsia conorii infections (Davi et al., 1995), Chagas disease (Petkova et al., 2000, 2001), and severe malaria (Dai et al., 2012; Machado et al., 2006; Wenisch et al., 1996a; Dietmann et al., 2008). In this minireview, we will discuss the role of endothelin in the pathogenesis of infectious processes.
Keywords: Blood brain barrier; Endothelin; Inflammation; Neuroinflammation; Parasitic disease; Pneumonia; Sepsis.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
References
-
- Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46(3):325–415. - PubMed
-
- Kedzierski RM, Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol. 2001;41:851–76. - PubMed
-
- Teder P, Noble P. A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. Am J Cell and Mol Biol. 2000;23:7–10. - PubMed
-
- Sessa WC, et al. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. BBRC. 1991;174:613–618. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
